Publications by authors named "Lin P Zhao"

Claim this Profile
L
Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.
Jeanne Chauffier, Vincent Jachiet, Maxime Battistella, Pierre Romero, Pierre Fenaux, Lin Pierre Zhao

JAMA Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting cardiovascular events in allogeneic hematopoietic stem cell transplant recipients.
Benjamin Sibilia, Trecy Gonçalves, Florian Chevillon, Lin Pierre Zhao, Michael Benayoun

Eur J Prev Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of erythroid-stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group.
Maël Heiblig, Vincent Jachiet, Jérôme Hadjadj, Lin Pierre Zhao, Thibault Comont

Hemasphere· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[VEXAS Syndrome].
Vincent Jachiet, Thibault Comont, Olivier Kosmider, Lin Pierre Zhao, Arsène Mekinian

Rev Prat· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOSAIC: An Artificial Intelligence-Based Framework for Multimodal Analysis, Classification, and Personalized Prognostic Assessment in Rare Cancers.
Saverio D'Amico, Lorenzo Dall'Olio, Cesare Rollo, Patricia Alonso, Iñigo Prada-Luengo, Lin Pierre Zhao

JCO Clin Cancer Inform· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.
Cristina A Tentori, Lin P Zhao, Benedetta Tinterri, Kathryn E Strange, Katharina Zoldan

Hemasphere· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases.
Vincent Jachiet, Laure Ricard, Pierre Hirsch, Florent Malard, Laurent Pascal, Lin Pierre Zhao

Clin Exp Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas.
Van Anh Ta, Maxime Battistella, Lin Pierre Zhao, Gabor Dobos, Caroline Ram-Wolff

J Invest Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML.
Arsene Mekinian, Lin Pierre Zhao, Sylvie Chevret, Kristell Desseaux, Laurent Pascal

Leukemia· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis